StockNews.com began coverage on shares of Amdocs (NASDAQ:DOX – Free Report) in a research note published on Thursday morning. The brokerage issued a buy rating on the technology company’s stock. Several other equities analysts have also recently issued reports on DOX. Oppenheimer raised their price target on Amdocs from $99.00 to $109.00 and gave the […]